Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2005
03/30/2005EP1517898A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases
03/30/2005EP1517897A2 Benzimidazole compounds and their use as estrogen agonists/antagonists
03/30/2005EP1517895A1 8-(biaryl) quinoline pde4 inhibitors
03/30/2005EP1517685A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses
03/30/2005EP1360184B1 Piperidine derivatives as neurokinin 1 antagonists
03/30/2005EP1237551B1 Pharmaceutical formulations containing zolmitriptan
03/30/2005EP1192127B1 Substituted benzamide inhibitors of rhinovirus 3c protease
03/30/2005EP0980369B1 Sulfonamides for treatment of endothelin-mediated disorders
03/30/2005CN1602196A Ureas of 2-aminobenzothiazoles as adenosine modulators
03/30/2005CN1602195A Quinazoline derivatives for the treatment of abnormal cell growth
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/30/2005CN1194975C Helerocyclic substituted benzoxazine cyclic compound having biological activity
03/29/2005US6872745 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
03/29/2005US6872740 4-(heteroarylethyl)-4,5-dihydro-1,3-thiazol-2-ylamine or salt, useful for treating an illness, which involves an abnormal production of nitric oxide (NO) by induction of an inducible NO-synthase
03/29/2005US6872732 Heterocyclic derivatives and medicinal use thereof
03/29/2005US6872728 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/29/2005CA2261760C Sulfonamides and derivatives thereof that modulate the activity of endothelin
03/29/2005CA2217169C Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
03/24/2005WO2005026165A1 Quinolone antibacterial agents
03/24/2005WO2005026163A1 Dioxolane derivatives as cell adhesion inhibitors
03/24/2005WO2005026161A1 Antibacterial agents
03/24/2005WO2005026160A1 Crystal of heterocyclic compound
03/24/2005WO2005026159A1 Benzoxazole acetonitriles
03/24/2005WO2005026158A1 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors
03/24/2005WO2005026156A1 Quinazoline derivatives
03/24/2005WO2005026155A1 Benzimidazole acetonitriles
03/24/2005WO2005026154A1 Quinolone antibacterial agents
03/24/2005WO2005026152A1 Quinazoline derivatives as antitumor agents
03/24/2005WO2005026149A1 Pyrrol derivatives with antibacterial activity
03/24/2005WO2005026134A1 Organic compounds
03/24/2005WO2005026133A1 Isoxazoles as peptide deformylase inhibitors
03/24/2005WO2005026129A1 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
03/24/2005WO2005026123A1 2-pyridone derivatives as neutrophil elastase inhibitors and their use
03/24/2005WO2005026113A1 1, 3-disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases
03/24/2005WO2005026111A2 Heteroaromatic selective inhibitors of neuronal nitric oxide synthase
03/24/2005WO2005025572A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
03/24/2005WO2005025555A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
03/24/2005WO2005025293A2 Fused ring heterocycles as potassium channel modulators
03/24/2005WO2005011657A3 Piperazine derivatives and their use as therapeutic agents
03/24/2005WO2005009967A3 Quinolinone derivatives as inhibitors of c-fms kinase
03/24/2005WO2005007648A3 Biaryl piperazinyl-pyridine analogues
03/24/2005WO2005005389A3 Malonamide derivatives
03/24/2005WO2004096135A3 Inhibitors of akt activity
03/24/2005WO2004085384A8 Bis-aryl sulfonamides
03/24/2005WO2004080925A3 Synthesis of tetrahydro-1,2-oxazines by the cycloaddition of nitrones with cyclopropanes
03/24/2005WO2004064730A3 Compounds, compositions and methods
03/24/2005US20050065353 Mitosis agents; antitumor agents; anticancer agents
03/24/2005US20050065340 Psychological disorders; anxiolytic agents; antidepressants; analgesics ; schizophrenia
03/24/2005US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors
03/24/2005US20050065187 Novel antimicrobial aryloxazolidinone compounds
03/24/2005US20050065164 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
03/24/2005US20050065163 Platelet adenosine diphosphate receptor antagonists
03/24/2005US20050065140 Antidepressant; side effect reduction
03/24/2005US20050065066 Stabilised insulin compositions
03/24/2005US20050064006 Stents
03/24/2005CA2541100A1 Quinazoline derivatives
03/24/2005CA2539160A1 Antibacterial agents
03/24/2005CA2539024A1 Quinazoline derivatives as antitumor agents
03/24/2005CA2539016A1 Organic compounds
03/24/2005CA2538909A1 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors
03/24/2005CA2538552A1 Pyrrol derivatives with antibacterial activity
03/24/2005CA2538425A1 Crystals of a heterocyclic compound
03/24/2005CA2538420A1 Quinolone antibacterial agents
03/24/2005CA2538339A1 Heteroaromatic selective inhibitors of neuronal nitric oxide synthase
03/24/2005CA2537660A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
03/24/2005CA2536633A1 Fused ring heterocycles as potassium channel modulators
03/23/2005EP1516903A1 Light-emitting compound and polymer and luminescent element
03/23/2005EP1516877A1 Amine derivatives as protease inhibitors
03/23/2005EP1515953A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
03/23/2005EP1515951A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors
03/23/2005EP1515726A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors
03/23/2005EP1515724A1 Mitotic kinesin inhibitors
03/23/2005EP1515722A2 Ophthalmic compositions for treating ocular hypertension
03/23/2005EP1515721A1 Ophthalmic compositions for treating ocular hypertension
03/23/2005EP1347969B1 5- (pyrazol-4-yl)carbonyl]benzazolone as herbicide
03/23/2005CN1599736A Process for the preparation of 4-(8-chloro-5, 6-dihydro-11h-benzo(5, 6)-cyclohepta-(1, 2b)-pyridin-11-ylidene)-1-piperidinecarboxyli c acid ethyl ester (loratadine)
03/23/2005CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/23/2005CN1599728A 1, 2, 4-triazole derivatives containing a sulphamate group as aromatase inhibitors
03/23/2005CN1599724A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
03/23/2005CN1599722A 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
03/23/2005CN1599717A Cyclic diamine compounds having fused-ring groups
03/23/2005CN1597682A Metal complex type luminous material containing electron injection group and its preparation method
03/23/2005CN1597681A Preparation of 1-[7- fluoro-4-propargyl-1, 4-benzo oxazine-3-(4H) ketone -6-keto]-3-n-propyl-2-thio imidazoline triketone herbicide
03/23/2005CN1597667A Quinazoline derivatives as angiogenesis inhibitors
03/23/2005CN1193788C Beta 2-adrenergic receptor agonist
03/22/2005US6870058 Polyhydroxy, dienyl lactones and intermediates
03/22/2005US6870055 Heterocyclic amides such as 3-dimethylaminomethyl-6-methoxy-2 -methyl-4-phenyl-2H-isoquinoline-1-one, used as antiarrhythmic agents
03/22/2005US6869969 Isoxazole estrogen receptor agonist and antagonist
03/22/2005US6869965 Such as 2-methylpropyl-(4-bromo-3-fluorophenyl)carbamate
03/22/2005US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
03/22/2005US6869943 Sorbitol dehydrogenase inhibitors
03/22/2005US6869913 Pyridazin-3-one derivatives, their use and intermediates for their production
03/22/2005CA2178219C Substituted morpholine derivatives and their use as therapeutic agents
03/17/2005WO2005023807A2 4 - heterobicyclyamino - substituted quinazolines and analogues therof as capsaicin - antagonists
03/17/2005WO2005023802A1 Pyridinylmorpholine derivatives
03/17/2005WO2005023801A1 Intermediate products for producing oxazolidinone-quinolone hybrids
03/17/2005WO2005023799A1 Fused bicyclic carboxamide derivatives and methods of their use
03/17/2005WO2005023777A1 Ppar-activating compound and pharmaceutical composition containing same
03/17/2005WO2005023251A1 N3 alkylated benzimidazole derivatives as mek inhibitors
03/17/2005WO2005023247A1 Compounds and methods
1 ... 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 ... 647